Phase I trial of nitisinone [SYN118] as adjunctive therapy in patients with advanced Parkinson's disease.
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2010
At a glance
- Drugs Nitisinone (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Synosia Therapeutics
- 29 Sep 2010 Results were presented at the World Parkinson Congress, according to a Synosia media release.
- 29 Sep 2010 New trial record